Casey Lynch
Chief Executive Officer, IRulya Therapeutics Inc.
Companies
- Longboard Pharmaceuticals, Inc.Board member Mar 11, 2021 to Dec 2, 20241
- IRulya Therapeutics Inc.Board member May 8, 2019 to Jan 5, 20222
- IRulya Therapeutics Inc.Chief executive officer May 8, 2019 to Jan 5, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- IRulya Therapeutics Inc. QNCX201,806 shares3$6.7M at $33.23Nov 19, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 18, 2021Exercised options 60,000 shares at $0.46 of IRulya Therapeutics Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3